pharmeasy: Goldman Sachs likely to invest Rs 2,700 crore in PharmEasy parent
Goldman Sachs is in superior talks to take a position about $350 million (Rs 2,700 crore) in API Holdings, the ...
Tag: pharmeasy
Goldman Sachs is in superior talks to take a position about $350 million (Rs 2,700 crore) in API Holdings, the ...